Company
United StatesPublic company, NYSE: ABTAbbott Laboratories (NYSE: ABT), Columbus, OH – FDA Inspections
Inspection records and compliance data for Abbott Laboratories in Columbus, Ohio. 1 FDA inspection on record, last inspected March 06, 2023. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories based in Columbus, Ohio, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 6, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 6, 2023 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1199207 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
3003611831
Address
3300 Stelzer Rd, Columbus, Ohio 43219, United States
Country
United States
ID: 0c22e68c-372a-493d-ade8-688c1c104bfa